Ledger.Open graph →
SEC Form D · filed July 25, 2016

Fulcrum Therapeutics, Inc

Offering
$55.0M
Sold
$17.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Levin · Cambridge, MADirectorRobert Gould · Cambridge, MAExec · DirectorJames Geraghty · Cambridge, MADirectorJennifer W. Cattier · New York, NYDirectorMatthew W. Kaplan · New York, NYExec · DirectorRichard R. Gilliam · Vancouver, British Columbia, CanadaDirectorPaddy Dear · Grand Cayman, Cayman IslandsExec · DirectorReade Griffith · Grand Cayman, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗